Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 38 articles:
HTML format
Text format



Single Articles


    April 2017
  1. MADAPURA HS, Nagy N, Ujvari D, Kallas T, et al
    Interferon gamma is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  2. SOCHALSKA M, Schuler F, Weiss JG, Prchal-Murphy M, et al
    MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesis.
    Oncogene. 2017;36:2066-2073.
    PubMed     Text format     Abstract available


    March 2017
  3. TAKAHASHI H, Inoue J, Sakaguchi K, Takagi M, et al
    Autophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells.
    Oncogene. 2017 Mar 27. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  4. FERREIRA HJ, Heyn H, Vizoso M, Moutinho C, et al
    DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia.
    Oncogene. 2017 Mar 13. doi: 10.1038/onc.2017.
    PubMed     Text format    


    February 2017
  5. VAN ATTEKUM MH, Terpstra S, Slinger E, von Lindern M, et al
    Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia.
    Oncogene. 2017 Feb 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  6. WAKIM J, Arman E, Becker-Herman S, Kramer MP, et al
    The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia.
    Oncogene. 2017 Feb 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    January 2017
  7. PRANGE KH, Mandoli A, Kuznetsova T, Wang SY, et al
    MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia.
    Oncogene. 2017 Jan 23. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  8. UGALE A, Sawen P, Dudenhoffer-Pfeifer M, Wahlestedt M, et al
    MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.
    Oncogene. 2017 Jan 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    December 2016
  9. POMEROY EJ, Lee LA, Lee RD, Schirm DK, et al
    Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia.
    Oncogene. 2016 Dec 19. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    November 2016
  10. SAFFERTHAL C, Rohde K, Fulda S
    Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells.
    Oncogene. 2016 Nov 21. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  11. GOYAMA S, Shrestha M, Schibler J, Rosenfeldt L, et al
    Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia.
    Oncogene. 2016 Nov 7. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    September 2016
  12. SMITH CI
    From identification of the BTK kinase to effective management of leukemia.
    Oncogene. 2016 Sep 26. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  13. STAFFAS A, Arabanian LS, Wei SY, Jansson A, et al
    Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice.
    Oncogene. 2016 Sep 12. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  14. HU Y, Su H, Liu C, Wang Z, et al
    DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  15. LEE-SHERICK AB, Eisenman KM, Sather S, McGranahan A, et al
    Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format    


    June 2016
  16. ELF S, Lin R, Xia S, Pan Y, et al
    Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin.
    Oncogene. 2016 Jun 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    May 2016
  17. BERNASCONI-ELIAS P, Hu T, Jenkins D, Firestone B, et al
    Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies.
    Oncogene. 2016 May 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    April 2016
  18. SU R, Dong L, Zou D, Zhao H, et al
    microRNA-23a, -27a and -24 synergistically regulate JAK1/Stat3 cascade and serve as novel therapeutic targets in human acute erythroid leukemia.
    Oncogene. 2016 Apr 18. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  19. LIU PP, Liu J, Jiang WQ, Carew JS, et al
    Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline.
    Oncogene. 2016 Apr 11. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    February 2016
  20. SLANY RK
    The molecular mechanics of mixed lineage leukemia.
    Oncogene. 2016 Feb 29. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    January 2016
  21. RODRIGUEZ-PERALES S, Torres-Ruiz R, Suela J, Acquadro F, et al
    Truncated RUNX1 protein generated by a novel t(1;21)(p32;q22) chromosomal translocation impairs the proliferation and differentiation of human hematopoietic progenitors.
    Oncogene. 2016;35:125-34.
    PubMed     Text format     Abstract available


  22. WIMMER P, Berscheminski J, Blanchette P, Groitl P, et al
    PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53.
    Oncogene. 2016;35:69-82.
    PubMed     Text format     Abstract available


    December 2015
  23. ZHAO Y, Masiello D, McMillian M, Nguyen C, et al
    CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells.
    Oncogene. 2015 Dec 14. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    November 2015
  24. MARJON KD, Termini CM, Karlen KL, Saito-Reis C, et al
    Tetraspanin CD82 regulates bone marrow homing of acute myeloid leukemia by modulating the molecular organization of N-cadherin.
    Oncogene. 2015 Nov 23. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    October 2015
  25. HELTEMES-HARRIS LM, Larson JD, Starr TK, Hubbard GK, et al
    Sleeping Beauty transposon screen identifies signaling modules that cooperate with STAT5 activation to induce B-cell acute lymphoblastic leukemia.
    Oncogene. 2015 Oct 26. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  26. FERREIRA HJ, Heyn H, Vizoso M, Moutinho C, et al
    DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia.
    Oncogene. 2015 Oct 5. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  27. GUAN D, Factor D, Liu Y, Wang Z, et al
    The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein.
    Oncogene. 2015;34:5206.
    PubMed     Text format    


    September 2015
  28. SHAIN KH, Dalton WS, Tao J
    The tumor microenvironment shapes hallmarks of mature B-cell malignancies.
    Oncogene. 2015;34:4673-82.
    PubMed     Text format     Abstract available


    July 2015
  29. EMMRICH S, Engeland F, El-Khatib M, Henke K, et al
    miR-139-5p controls translation in myeloid leukemia through EIF4G2.
    Oncogene. 2015 Jul 13. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  30. SOTOCA AM, Prange KH, Reijnders B, Mandoli A, et al
    The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia.
    Oncogene. 2015 Jul 6. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    June 2015
  31. COLLINS CT, Hess JL
    Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets.
    Oncogene. 2015 Jun 1. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  32. THOMAS A, Perry T, Berhane S, Oldreive C, et al
    The dual-acting chemotherapeutic agent Alchemix induces cell death independently of ATM and p53.
    Oncogene. 2015;34:3336-48.
    PubMed     Text format     Abstract available


    May 2015
  33. HONDA H, Nagamachi A, Inaba T
    -7/7q- syndrome in myeloid-lineage hematopoietic malignancies: attempts to understand this complex disease entity.
    Oncogene. 2015;34:2413-25.
    PubMed     Text format     Abstract available


    April 2015
  34. LI Y, Luo H, Liu T, Zacksenhaus E, et al
    The ets transcription factor Fli-1 in development, cancer and disease.
    Oncogene. 2015;34:2022-31.
    PubMed     Text format     Abstract available


  35. GUO G, Kang Q, Zhu X, Chen Q, et al
    A long noncoding RNA critically regulates Bcr-Abl-mediated cellular transformation by acting as a competitive endogenous RNA.
    Oncogene. 2015;34:1768-79.
    PubMed     Text format     Abstract available


    March 2015
  36. GIRARDOT M, Pecquet C, Chachoua I, Van Hees J, et al
    Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulation.
    Oncogene. 2015;34:1323-32.
    PubMed     Text format     Abstract available


    November 2014
  37. TOMIATTI V, Istvanffy R, Pietschmann E, Kratzat S, et al
    Cks1 is a critical regulator of hematopoietic stem cell quiescence and cycling, operating upstream of Cdk inhibitors.
    Oncogene. 2014;0.
    PubMed     Text format     Abstract available


    June 2014
  38. FAN D, Zhou X, Li Z, Li ZQ, et al
    Stem cell programs are retained in human leukemic lymphoblasts.
    Oncogene. 2014 Jun 9. doi: 10.1038/onc.2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: